Skip to main content
. 2015 Dec 11;10(12):e0144376. doi: 10.1371/journal.pone.0144376

Fig 2. Comparisons of LMVD in different subgroups.

Fig 2

(A) LMVD in the BCYW and BCMEW groups and in the control group. LMVD in either BCYW or BCMEW was significantly higher than that in the breast proliferative lesions. However, no significant difference was found between the BCYW and BCMEW groups. (B) LMVD in breast cancer patients with or without LNM was not significantly different. (C) LMVD was not significantly different according to lymph node status in both the BCYW and BCMEW groups (Mann-Whitney U-test).